Drug profile · INN
lovastatin
LOVASTATIN
lovastatin (LOVASTATIN) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — lovastatin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
lovastatin (LOVASTATIN) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
HMG-CoA reductase inhibitor
Primary target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lovastatin?
lovastatin (LOVASTATIN) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lovastatin?
LOVASTATIN is a marketed brand name for lovastatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lovastatin?
lovastatin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.